Remicade 100mg 1 Vial (Refrigerated)

Active Ingredient: Infliximab Ankylosing spondylitis: Treatment of adults with active ankylosing spondylitis (to reduce signs/symptoms) Crohn disease: Treatment of adults and pediatric patients ≥6 years with moderately to severely active Crohn disease who have had inadequate responses to conventional therapy (to reduce signs/symptoms and induce and maintain clinical remission) or to reduce the number of draining enterocutaneous and rectovaginal fistulas and maintain fistula closure in adults Plaque psoriasis: Treatment of adults with chronic, severe (extensive and/or disabling) plaque psoriasis as an alternative to other systemic therapy Psoriatic arthritis: Treatment of adults with psoriatic arthritis (to reduce signs/symptoms of active arthritis and inhibit progression of structural damage and improve physical function) Rheumatoid arthritis: Treatment of adults with moderately to severely active rheumatoid arthritis (with methotrexate) (to reduce signs/symptoms of active arthritis and inhibit progression of structural damage and improve physical function) Ulcerative colitis: Treatment of adults and pediatric patients ≥6 years (Remicade only) with moderately to severely active ulcerative colitis with inadequate response to conventional therapy (to reduce signs/symptoms and induce and maintain clinical remission and mucosal healing and eliminate corticosteroid use)